An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate.

Ian McGowan,Ratiya Pamela Kunjara Na Ayudhya,Rhonda M. Brand,Mark A. Marzinke,Craig W. Hendrix,Sherri Johnson,Jeanna M. Piper,Timothy H Holtz,Marcel E. Curlin,Anupong Chitwarakorn,Boonyos Raengsakulrach,Gustavo F. Doncel,James F. Rooney,Ross D. Cranston

An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine / Tenofovir Disoproxil Fumarate.

2021

Ian McGowan
Ratiya Pamela Kunjara Na Ayudhya
Rhonda M. Brand
Mark A. Marzinke
Craig W. Hendrix
Sherri Johnson
Jeanna M. Piper
Timothy H Holtz
Marcel E. Curlin
Anupong Chitwarakorn
Boonyos Raengsakulrach
Gustavo F. Doncel
James F. Rooney
Ross D. Cranston

The MTN-017 study was undertaken to characterize the safety, acceptability, pharmacokinetic, and pharmacodynamic profile of the reduced-glycerin (RG) 1% tenofovir (RG-TFV) gel compared to oral emtr...

Keywords:

Pharmacodynamics
Emtricitabine/Tenofovir Disoproxil Fumarate
Pharmacology
Medicine
open label
Pharmacokinetics
Tenofovir

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations